News / Taiwan / economic_daily
MediGrace Reaches Settlement with Terumo, Boosting Q3 Earnings
Health Technology · Medical Specialties · economic_daily · 2026-09-20
6499
MediGrace has finalized a settlement agreement with Terumo Medical Corporation, securing $6 million in payments to be recognized in the third quarter.
What Happened
Settlement Agreement: After over a year of negotiations, MediGrace and Terumo have signed a settlement and termination agreement regarding their collaboration on the Cross-Seal large-bore vascular closure device.
Financial Impact: The company will receive a $6 million settlement payment, which is expected to contribute positively to its earnings in the third quarter.
Contract Termination: With the termination of the agreement, the remaining $19 million in potential milestone payments is canceled, though MediGrace retains all previously collected milestone payments.
Strategic Focus: This resolution allows MediGrace to move forward from the partnership, focusing its resources on future product development and strategic market initiatives.